Harvard Bioscience, Inc. (HBIO) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $3.56 -3.52%
EPS Growth %: -16.7%
Financial Fact:
Interest income: 1K
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -16.7%
Financial Fact:
Interest income: 1K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q1 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $25.9 million, versus $26.1 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
